Retension Pharmaceuticals appointed Robert Wong as Vice President and Chief Accounting Officer, effective November 2, 2026. His compensation package includes an annual base salary of $360,000, a 30% target bonus opportunity, a $20,000 sign-on bonus, and a stock option award for 25,000 shares.
Retension Pharmaceuticals CEO Eric L. Keller Buys $250K of Stock
Eric L. Keller, CEO, bought 20,800 shares of Retension Pharmaceuticals, Inc. at $12.00 a share, worth $250K in total on Oct 13, 2026. Shares held after the trade: 423,377 (+5.2%).
Retension Pharmaceuticals Insider Franklin M. Berger Buys $120K of Stock
Franklin M. Berger bought 10,000 shares of Retension Pharmaceuticals, Inc. at $12.00 a share, worth $120K in total on Oct 13, 2026. Shares held after the trade: 10,000.